Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

A lentiviral vaccine expressing KMP11-HASPB fusion protein increases immune response to Leishmania major in BALB/C.

Mortazavidehkordi N, Fallah A, Abdollahi A, Kia V, Khanahmad H, Najafabadi ZG, Hashemi N, Estiri B, Roudbari Z, Najafi A, Farjadfar A, Hejazi SH.

Parasitol Res. 2018 Jul;117(7):2265-2273. doi: 10.1007/s00436-018-5915-6. Epub 2018 May 29.

PMID:
29845415
2.

Suppression of dsRNA response genes and innate immunity following Oct4, Stella, and Nanos2 overexpression in mouse embryonic fibroblasts.

Farshchian M, Matin MM, Armant O, Geerts D, Dastpak M, Nakhaei-Rad S, Tajeran M, Jebelli A, Shahriyari M, Bahrami M, Fallah A, Yaghoobi V, Mirahmadi M, Abbaszadegan MR, Bahrami AR.

Cytokine. 2018 Jun;106:1-11. doi: 10.1016/j.cyto.2018.02.021. Epub 2018 Mar 7.

PMID:
29501710
3.

Stable Knockdown of Adenosine Kinase by Lentiviral Anti-ADK miR-shRNAs in Wharton's Jelly Stem Cells.

Estiri H, Fallah A, Soleimani M, Aliaghaei A, Karimzadeh F, Babaei Abraki S, Ghahremani MH.

Cell J. 2018 Apr;20(1):1-9. doi: 10.22074/cellj.2018.4916. Epub 2017 Dec 1.

4.

Multiple Sclerosis Gene Therapy with Recombinant Viral Vectors: Overexpression of IL-4, Leukemia Inhibitory Factor, and IL-10 in Wharton's Jelly Stem Cells Used in EAE Mice Model.

Hosseini A, Estiri H, Akhavan Niaki H, Alizadeh A, Abdolhossein Zadeh B, Ghaderian SMH, Farjadfar A, Fallah A.

Cell J. 2017 Oct;19(3):361-374. doi: 10.22074/cellj.2017.4497. Epub 2017 Aug 19.

Supplemental Content

Loading ...
Support Center